Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Apr-24 7:03 PM View:  | Enliven Therapeutics, Inc. (ELVN) | 15-Apr-24 | Sale (Planned) | 1,270 | $19.99 | $25,383.10 | (< 1%) 204.4K to 203.13K | |
| 15-Apr-24 7:03 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Private Sale (Planned) | 5,045 | $25.03 | $126,279.00 | (7%) 71.81K to 66.76K | |
| 15-Apr-24 7:03 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Sale (Planned) | 649 | $25.00 | $16,225.00 | (< 1%) 66.76K to 66.11K | |
| 21-Mar-24 6:41 PM View: | Enliven Therapeutics, Inc. (ELVN) | 19-Mar-24 | Private Sale (Planned) | 1,270 | $14.50 | $18,418.70 | (< 1%) 211.36K to 210.09K | |
| 27-Feb-24 4:59 PM View: | Rayzebio, Inc. (RYZB) | 26-Feb-24 | Disposition | 367,446 | $62.50 | $22,965,400.00 | (100%) 367.45K to 0 | |
| 20-Feb-24 7:41 PM View: | Enliven Therapeutics, Inc. (ELVN) | 15-Feb-24 | Private Sale (Planned) | 1,270 | $17.42 | $22,117.40 | (< 1%) 212.63K to 211.36K | |
| 01-Feb-24 8:10 PM View: | Enliven Therapeutics, Inc. (ELVN) | 30-Jan-24 | Private Sale (Planned) | 1,270 | $16.41 | $20,839.60 | (< 1%) 213.9K to 212.63K | |
| 26-Dec-23 7:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Dec-23 | Sale (Planned) | 168 | $13.00 | $2,184.00 | (< 1%) 214.11K to 213.94K | |
| 26-Dec-23 7:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Dec-23 | Sale (Planned) | 35 | $13.00 | $455.00 | (< 1%) 213.94K to 213.9K | |
| 26-Dec-23 7:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Dec-23 | Private Sale (Planned) | 7 | $13.00 | $91.00 | (< 1%) 214.12K to 214.11K | |
| 26-Dec-23 7:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Dec-23 | Sale (Planned) | 6 | $13.00 | $78.00 | (< 1%) 214.11K to 214.11K | |
| 21-Dec-23 4:28 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Dec-23 | Sale (Planned) | 2,110 | $13.02 | $27,472.60 | (< 1%) 218.14K to 216.03K | |
| 21-Dec-23 4:28 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Dec-23 | Sale (Planned) | 1,915 | $13.02 | $24,939.40 | (< 1%) 216.03K to 214.12K | |
| 21-Dec-23 4:28 PM View: | Enliven Therapeutics, Inc. (ELVN) | 19-Dec-23 | Private Sale (Planned) | 255 | $13.00 | $3,315.00 | (< 1%) 218.4K to 218.14K | |
| 27-Feb-23 9:54 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant | 149,820 | -- | -- | 100% 0 to 149.82K | |
| 27-Feb-23 9:54 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant | 68,579 | -- | -- | 46% 149.82K to 218.4K | |
| 16-Sep-21 6:19 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 15-Sep-21 | Market Sale (Planned) | 682 | $25.03 | $17,073.70 | (< 1%) 229.45K to 228.77K | (< 1%) |
| 16-Sep-21 6:19 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 14-Sep-21 | Market Sale (Planned) | 706 | $25.05 | $17,686.10 | (< 1%) 230.16K to 229.45K | (< 1%) |
| 09-Sep-21 4:36 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 07-Sep-21 | Market Sale (Planned) | 1,086 | $25.11 | $27,272.20 | (< 1%) 232.33K to 231.24K | 6% |
| 02-Jun-21 4:11 PM View: | Pmv Pharmaceuticals, Inc. (PMVP) | 01-Jun-21 | Option Exercise | 3,900 | $245.96 | $959,254.00 | 100% 0 to 3.9K | |
| 02-Jun-21 4:11 PM View: | Pmv Pharmaceuticals, Inc. (PMVP) | 01-Jun-21 | Market Option Sale (Planned) | 3,900 | $32.55 | $126,935.00 | (100%) 3.9K to 0 | |
| 24-May-21 7:30 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 24-May-21 | Market Sale (Planned) Duplicate | 100 | $25.00 | $2,500.00 | (< 1%) 232.43K to 232.33K | 1% |
| 24-May-21 7:30 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 21-May-21 | Market Sale (Planned) | 600 | $25.25 | $15,150.00 | (< 1%) 233.03K to 232.43K | 2% |
| 24-May-21 7:30 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 20-May-21 | Market Sale (Planned) | 700 | $25.08 | $17,558.00 | (< 1%) 233.73K to 233.03K | 2% |
| 18-May-21 8:22 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 18-May-21 | Market Sale (Planned) | 2,161 | $25.32 | $54,715.40 | (< 1%) 235.89K to 233.73K | 3% |
| 18-May-21 8:22 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 17-May-21 | Market Sale (Planned) | 498 | $25.07 | $12,483.80 | (< 1%) 236.38K to 235.89K | 2% |
| 18-May-21 8:22 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 14-May-21 | Market Sale (Planned) | 3,215 | $25.31 | $81,382.30 | (1%) 239.6K to 236.38K | 3% |
| 13-May-21 8:00 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 11-May-21 | Market Sale (Planned) | 100 | $25.11 | $2,511.00 | (< 1%) 239.7K to 239.6K | 2% |
| 30-Apr-21 7:59 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 30-Apr-21 | Market Sale (Planned) | 100 | $25.26 | $2,526.00 | (< 1%) 239.8K to 239.7K | 2% |
| 30-Apr-21 7:59 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 28-Apr-21 | Market Sale (Planned) | 100 | $25.08 | $2,508.00 | (< 1%) 239.9K to 239.8K | 2% |
| 05-Apr-21 7:42 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 01-Apr-21 | Private Sale (Planned) | 100 | $25.00 | $2,500.00 | (< 1%) 240.0K to 239.9K | |
| 03-Feb-21 6:38 PM View: | Kineta, Inc./de (KA) | 01-Feb-21 | Grant | 1,959 | -- | -- | 32% 6.16K to 8.12K | |
| 28-Dec-20 7:10 PM View: | Kineta, Inc./de (KA) | 22-Dec-20 | Grant | 6,158 | -- | -- | 100% 0 to 6.16K | |
| 28-Apr-20 5:08 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 28-Apr-20 | Conversion Duplicate | 62,500 | -- | -- | 35% 177.5K to 240.0K | |
| 27-Aug-15 6:31 PM View: | Receptos, Inc. (RCPT) | 27-Aug-15 | Disposition | 7,400 | -- | -- | (100%) 7.4K to 0 | |
| 01-Jun-15 8:45 PM View: | Receptos, Inc. (RCPT) | 28-May-15 | Grant | 7,400 | -- | -- | 100% 0 to 7.4K |